Crossmark

A 16-week split-face randomized placebo controlled study on the utility of adding intradermal platelet rich plasma to 2% hydroquinone cream in the treatment of melasma

Crossref DOI link: https://doi.org/10.1007/s00403-025-04337-1

Published Online: 2025-07-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chhajed, Neelam

Singh, Saurabh https://orcid.org/0000-0003-4356-6883
Bains, Anupama

Bhardwaj, Abhishek

Budania, Anil

Lahoria, Utkrist

Kaur, Maninder

Mishra, Richa

Mandal, Saptarshi
License Information

Text and Data Mining valid from 2025-07-26

Version of Record valid from 2025-07-26
More Information

Article History

Received: 23 March 2025

Revised: 17 June 2025

Accepted: 11 July 2025

First Online: 26 July 2025

Change Date: 27 August 2025

Change Type: Update

Change Details: The original online version of this article was revised to correct the article title.

Change Date: 25 August 2025

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s00403-025-04350-4

Declarations

:

: The authors declare no competing interests.

Updates are available Correction dated 2025-08-25

Click to view Correction: https://doi.org/10.1007/s00403-025-04350-4